Published in Arch Dermatol on January 01, 1998
Epidemiology of invasive cutaneous melanoma. Ann Oncol (2009) 2.21
Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg (2010) 1.46
Melanoma screening with cellular phones. PLoS One (2007) 1.06
'This isn't what mine looked like': a qualitative study of symptom appraisal and help seeking in people recently diagnosed with melanoma. BMJ Open (2014) 0.97
Strategies for early melanoma detection: Approaches to the patient with nevi. J Am Acad Dermatol (2009) 0.93
Dermoscopy for melanoma detection in family practice. Can Fam Physician (2012) 0.92
The importance of a full clinical examination: assessment of index lesions referred to a skin cancer clinic without a total body skin examination would miss one in three melanomas. Acta Derm Venereol (2013) 0.89
Novice identification of melanoma: not quite as straightforward as the ABCDs. Acta Derm Venereol (2011) 0.87
When algorithms falter: a case report of a very small melanoma excised due to the dermatoscopic "ugly duckling" sign. Dermatol Pract Concept (2013) 0.86
Strategies for early recognition of cutaneous melanoma-present and future. Dermatol Pract Concept (2012) 0.86
Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial on efficacy and safety. Br J Dermatol (2014) 0.84
BLINCK-A diagnostic algorithm for skin cancer diagnosis combining clinical features with dermatoscopy findings. Dermatol Pract Concept (2012) 0.82
Malignant melanoma: a pictorial review. Ulster Med J (2014) 0.80
The study of nevi in children: Principles learned and implications for melanoma diagnosis. J Am Acad Dermatol (2016) 0.75
Abrupt Intralesional Color Change on Dermoscopy as a New Indicator of Early Superficial Spreading Melanoma in a Japanese Woman. Case Rep Dermatol (2015) 0.75
Assessment of Patient Knowledge of Longitudinal Melanonychia: A Survey Study of Patients in Outpatient Clinics. Skin Appendage Disord (2016) 0.75
Signature nevi: individuals with multiple melanocytic nevi commonly have similar clinical and histologic patterns. Dermatol Pract Concept (2011) 0.75
The ABCDEF Rule: Combining the "ABCDE Rule" and the "Ugly Duckling Sign" in an Effort to Improve Patient Self-Screening Examinations. J Clin Aesthet Dermatol (2015) 0.75
A series of small-diameter melanomas on the legs: dermoscopic clues for early recognition. Dermatol Pract Concept (2015) 0.75
Histopathological characteristics of small diameter melanocytic naevi. J Clin Pathol (2003) 0.75
Patient concern as a predictor of cutaneous malignancy. Br J Dermatol (2015) 0.75
Skin self-examinations and visual identification of atypical nevi: comparing individual and crowdsourcing approaches. Cancer Epidemiol (2013) 0.75
The melanoma epidemic. Is increased surveillance the solution or the problem? Arch Dermatol (1996) 3.49
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
Fotemustine compared with dacarbazine in patients with disseminated malignant melanoma: a phase III study. J Clin Oncol (2004) 3.97
Melanoma and tumor thickness: challenges of early diagnosis. Arch Dermatol (1999) 2.34
Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ (1999) 1.79
Ofuji papuloerythroderma. Report of a case with T cell skin lymphoma and discussion of the nature of this disease. J Am Acad Dermatol (1989) 1.42
Unfading acral microlivedo. A discrete marker of thrombotic skin disease associated with antiphospholipid antibody syndrome. J Am Acad Dermatol (1991) 1.39
Delays in diagnosis and melanoma prognosis (I): the role of patients. Int J Cancer (2000) 1.29
Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am J Pathol (1991) 1.16
Post-transplant plasmablastic lymphoma of the skin. Br J Dermatol (2003) 1.12
Skin tolerance and effectiveness of two hand decontamination procedures in everyday hospital use. Br J Dermatol (2000) 1.10
Insulin-induced lipoatrophy in type I diabetes. A possible tumor necrosis factor-alpha-mediated dedifferentiation of adipocytes. Diabetes Care (1996) 1.05
Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer (1990) 1.02
First isolation and detection by immunofluorescence assay of Bartonella koehlerae in erythrocytes from a French cat. J Clin Microbiol (2003) 1.00
Delays in diagnosis and melanoma prognosis (II): the role of doctors. Int J Cancer (2000) 0.98
Keratitis, ichthyosis, and deafness (KID) syndrome. Vertical transmission and death from multiple squamous cell carcinomas. Arch Dermatol (1987) 0.97
The relation between seborrheic keratoses and malignant solid tumours. A case-control study. Acta Derm Venereol (1991) 0.96
[Multiple trichoepithelioma, cylindroma, miliaria and carcinomatous transformation]. Ann Dermatol Venereol (1992) 0.94
Psoriasis in France and associated risk factors: results of a case-control study based on a large community survey. Dermatology (2008) 0.93
Induction of late cutaneous reaction by kallikrein injection: comparison with allergic-like late response to compound 48/80. J Allergy Clin Immunol (1983) 0.93
Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions. J Eur Acad Dermatol Venereol (2011) 0.92
NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer (1994) 0.92
Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol (1995) 0.92
Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol (2011) 0.92
An association between autosomal dominant cerebral cavernomas and a distinctive hyperkeratotic cutaneous vascular malformation in 4 families. Ann Neurol (1999) 0.91
Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée. Eur J Cancer (1998) 0.91
Tyrosinase gene expression in human tissues. Pigment Cell Res (1993) 0.89
Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy (2011) 0.88
Identification by cDNA microarray technology of genes modulated by artificial ultraviolet radiation in normal human melanocytes: relation to melanocarcinogenesis. J Invest Dermatol (2001) 0.88
Cost-effectiveness of surveillance of stage I melanoma. A retrospective appraisal based on a 10-year experience in a dermatology department in France. Dermatology (1995) 0.88
Chemotherapy by fotemustine in cerebral metastases of disseminated malignant melanoma. Cancer Chemother Pharmacol (1990) 0.87
White blood cell count: a prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma. Clin Cancer Res (2000) 0.87
Management of pain associated with debridement of leg ulcers: a randomized, multicentre, pilot study comparing nitrous oxide-oxygen mixture inhalation and lidocaïne-prilocaïne cream. J Eur Acad Dermatol Venereol (2010) 0.87
[Fibrosing lupus erythematosus panniculitis in a pregnant woman with anti-RO/SSA antibodies in mother and child]. Ann Dermatol Venereol (1987) 0.86
[Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases]. Ann Dermatol Venereol (2001) 0.85
Thrombotic skin disease as a marker of the anticardiolipin syndrome. Livedo vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J Am Acad Dermatol (1989) 0.85
Treatment of large basal-cell carcinomas with intralesional interferon-alpha-2a. Lancet (1988) 0.84
[Erosive pustulosis of the scalp. A spongiform pustular dermatosis?]. Ann Dermatol Venereol (1993) 0.83
Economic analysis of adjuvant therapy with interferon alpha-2a in stage II malignant melanoma. Eur J Cancer (2001) 0.83
Role of tumor necrosis factor-alpha in Sneddon-Wilkinson subcorneal pustular dermatosis. A model of neutrophil priming in vivo. J Am Acad Dermatol (1991) 0.82
[Congenital hypotrichosis and milia with spontaneous regression during adolescence or Oley syndrome: a variant of Bazex-Dupré-Christol syndrome]. Ann Dermatol Venereol (2000) 0.82
[Kaposi's disease. Ultrastructural study of 4 cases]. Ann Dermatol Syphiligr (Paris) (1975) 0.82
Pancreatitis associated protein I (PAP-I) alters adhesion and motility of human melanocytes and melanoma cells. J Invest Dermatol (2001) 0.81
Dysplastic naevus in non-familial melanoma. A clinicopathological study of 101 cases. Br J Dermatol (1988) 0.81
[Bullous cutaneous localization with epidermotropism in monoblastic leukemia]. Ann Dermatol Venereol (1988) 0.81
Cutaneous manifestations associated with the presence of the lupus anticoagulant. A report of two cases and a review of the literature. J Am Acad Dermatol (1986) 0.81
Humour and alarmism in melanoma prevention: a randomized controlled study of three types of information leaflet. Br J Dermatol (1999) 0.80
[Appearance of a pallido-striated syndrome with torsion spasms and athetosis in a case of viral hepatitis]. Mars Med (1965) 0.80
Expression of FGF1 and FGFR1 in human melanoma tissues. Melanoma Res (1996) 0.80
Palmoplantar orthokeratotic filiform hyperkeratosis in a patient with associated Darier's disease. Classification of filiform hyperkeratosis. Dermatology (1992) 0.79
[Erosive and pustular scalp diseases]. Ann Dermatol Venereol (1999) 0.79
[Melanic proliferations of the conjunctiva. Histopathologic study of a series of 40 cases]. J Fr Ophtalmol (1985) 0.78
[Skin manifestations associated with myelodysplastic syndromes]. Rev Med Interne (2001) 0.78
[Hirsutoid papilloma of the vulva]. Ann Dermatol Venereol (1987) 0.78
Contact allergies in haemodialysis patients: a prospective study of 75 patients. Allergy (2009) 0.78
Extra-anogenital HPV16-related bowenoid papulosis. Genitourin Med (1991) 0.78
High negative predictive value of slow lymphatic drainage on metastatic node spread detection in malignant limb and trunk cutaneous melanoma. Bull Cancer (2004) 0.77
[Morel-Lavallee syndrome of the lower leg]. Ann Dermatol Venereol (2012) 0.77
Combined treatment with dacarbazine, cisplatin, fotemustine and tamoxifen in metastatic malignant melanoma. Melanoma Res (1998) 0.77
Melanoma prevention: evaluation of a health education campaign for primary schools. Arch Dermatol (1999) 0.77
[Thrombotic accidents induced by thalidomide: two cases]. Rev Med Interne (2002) 0.77
[Epithelial and melanotic skin tumors. Epithelial carcinoma]. Ann Dermatol Venereol (2002) 0.77
Physiopathogenic investigations in a case of familial stiff-skin syndrome. Dermatology (1998) 0.77
Development and validation of a quality of life measurement for chronic skin disorders in french: VQ-Dermato. The RéseaudEpidémiolo gie en Dermatologie. Dermatology (1999) 0.77
Multiple senile lentigos of the face, a skin ageing pattern resulting from a life excess of intermittent sun exposure in dark-skinned caucasians: a case-control study. Br J Dermatol (2006) 0.77
[Treatment of metastatic melanoma with dacarbazine recombinant interferon alfa 2A combination: results of multicentric study]. Bull Cancer (1990) 0.77
Large keratoacanthomas treated with intralesional interferon alfa-2a. J Am Acad Dermatol (1993) 0.77
Study of sunbathing habits in children and adolescents: application to the prevention of melanoma. Dermatology (1993) 0.76
[Fever with skin rash and polyarthralgia in a genetically black-skinned woman]. Med Trop (Mars) (2008) 0.76
Role of sun exposure on nevus. First study in age-sex phenotype-controlled populations. Arch Dermatol (1993) 0.76
Chronic eosinophilic leukaemia revealed by lymphomatoid papulosis: the role of the FIP1-like 1-platelet-derived growth factor receptor alpha fusion gene. J Eur Acad Dermatol Venereol (2009) 0.76
[Role of sun exposure on benign melanocytic nevi. A first study in populations controlled for age, sex and phenotype]. Ann Dermatol Venereol (1994) 0.76
Sweet's syndrome induced by granulocyte colony-stimulating factor in a woman with congenital neutropenia. J Am Acad Dermatol (1996) 0.76
[Extracorporeal photochemotherapy in therapy-refractory subacute lupus]. Ann Dermatol Venereol (2002) 0.76
Multiple primary melanoma is not a distinct biological entity. Arch Dermatol (1999) 0.75
Adhesive and migratory behaviors of nevus cells differ from those of epidermal melanocytes and are not linked to the histological type of nevus. J Invest Dermatol (1996) 0.75